Skip to main content
. 2021 Feb 12;5(4):985–993. doi: 10.1182/bloodadvances.2020003654

Figure 1.

Figure 1.

NRM and relapse incidence rates. (A) The 2-year incidences of NRM were 24% (95% CI, 18%-31%) and 34% (95% CI, 30%-39%) after HLA-haploidentical relative and HLA-matched unrelated donor transplantations, respectively. (B) The 2-year incidences of relapse were 48% (95% CI, 39%-56%) and 33% (95% CI, 28%-37%) after HLA-haploidentical relative and HLA-matched unrelated donor transplantations, respectively.